- Home
- ATNM vs DVLT Comparison
ATNM vs DVLT Comparison
Compare ATNM & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- DVLT
- Stock Information
- Founded
- ATNM 2000
- DVLT 2010
- Country
- ATNM United States
- DVLT United States
- Employees
- ATNM N/A
- DVLT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- DVLT
- Sector
- ATNM Health Care
- DVLT
- Exchange
- ATNM Nasdaq
- DVLT NYSE
- Market Cap
- ATNM 51.5M
- DVLT 55.7M
- IPO Year
- ATNM N/A
- DVLT N/A
- Fundamental
- Price
- ATNM $1.47
- DVLT $0.72
- Analyst Decision
- ATNM Strong Buy
- DVLT Strong Buy
- Analyst Count
- ATNM 3
- DVLT 1
- Target Price
- ATNM $4.67
- DVLT $3.00
- AVG Volume (30 Days)
- ATNM 518.4K
- DVLT 485.8K
- Earning Date
- ATNM 08-04-2025
- DVLT 08-13-2025
- Dividend Yield
- ATNM N/A
- DVLT N/A
- EPS Growth
- ATNM N/A
- DVLT N/A
- EPS
- ATNM N/A
- DVLT N/A
- Revenue
- ATNM N/A
- DVLT $3,048,000.00
- Revenue This Year
- ATNM N/A
- DVLT $434.03
- Revenue Next Year
- ATNM N/A
- DVLT $221.43
- P/E Ratio
- ATNM N/A
- DVLT N/A
- Revenue Growth
- ATNM N/A
- DVLT 63.08
- 52 Week Low
- ATNM $1.03
- DVLT $0.60
- 52 Week High
- ATNM $8.64
- DVLT $3.34
- Technical
- Relative Strength Index (RSI)
- ATNM 44.59
- DVLT N/A
- Support Level
- ATNM $1.41
- DVLT N/A
- Resistance Level
- ATNM $1.49
- DVLT N/A
- Average True Range (ATR)
- ATNM 0.12
- DVLT 0.00
- MACD
- ATNM -0.02
- DVLT 0.00
- Stochastic Oscillator
- ATNM 25.00
- DVLT 0.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.